| dbo:abstract
|
- ماورو فيراري (بالإيطالية: Mauro Ferrari) هو عالم إيطالي، ولد في 1959 في أوديني في إيطاليا. (ar)
- Mauro Ferrari (Padua, 7 de julio de 1959) es un profesor y científico italiano. Experto en el campo de la nanotecnología y de la bioingeniería aplicada a la medicina, ha sido presidente y CEO del Houston Methodist Research Institute, director del Institute of Academic Medicine del Methodist Hospital System (TMHS) y presidente de The Alliance for NanoHealth. En enero de 2020 fue nombrado presidente del Consejo Europeo de Investigación, cargo del que dimitió en abril de 2020 por la crisis del coronavirus. (es)
- Mauro Ferrari (born 7 July 1959) is a nanoscientist and leader in the field of nanomedicine. He served as special expert on nanotechnology for the National Cancer Institute (2003-2005) and was instrumental in establishing the Alliance for Nanotechnology in Cancer in 2004.On 1 January 2020, Ferrari was made president of the European Research Council (ERC). Following a vote of no confidence, on 27 March 2020, "all 19 active members of the ERC’s Scientific Council individually and unanimously requested that Mauro Ferrari resign from his position as ERC’s President", due to poor conduct in office, exploiting the position to further his own projects, and for consistently failing to represent the interests of the ERC. On 7 April 2020, Ferrari officially resigned, stating to the media that he was "extremely disappointed by the European response” to the pandemic and expressing frustration over opposition to his efforts to launch a scientific program to combat the virus. (en)
- Mauro Ferrari (Udine, 7 luglio 1959) è un accademico bioingegnere e ricercatore italiano, impegnato principalmente nella ricerca sulle nanotecnologie e nel campo della bioingegneria applicate in medicina. È presidente e CEO del Houston Methodist Research Institute, direttore dal 2013 dell'Institute of Academic Medicine del Methodist Hospital System ed Executive Vice President del Methodist Hospital System (TMHS). È presidente della The Alliance for NanoHealth. (it)
|
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:award
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:institution
| |
| dbo:knownFor
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 30518 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
|
- (en)
- University of California Berkeley MS, PhD (en)
- University of Padova, Italy Dottore, Mathematics) (en)
|
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:caption
|
- Mauro Ferrari in 2010 (en)
|
| dbp:children
| |
| dbp:field
| |
| dbp:knownFor
|
- Bioethics (en)
- Nanomedicine (en)
- (en)
- Drug delivery (en)
- Nanofluidics (en)
- Biomedical microtechnology (en)
- Cancer Therapeutics (en)
|
| dbp:name
| |
| dbp:nationality
|
- Italy, United States (en)
|
| dbp:prizes
|
- (en)
- Fellow, American Association for the Advancement of Science (en)
- Aurel Stodola Medal (en)
- Blaise Pascal Medal in Biomedical Engineering (en)
- Department of Defense Innovator Award (en)
- National Academy of Sciences Europe (en)
- National Academy of Sciences Italy (en)
|
| dbp:spouse
|
- 1995 (xsd:integer)
- (en)
- Paola Ferrari (en)
|
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
|
- Ohio State University (en)
- University of Texas (en)
- (en)
- National Cancer Institute (en)
- University of California Berkeley (en)
- Houston Methodist (en)
|
| dcterms:subject
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- ماورو فيراري (بالإيطالية: Mauro Ferrari) هو عالم إيطالي، ولد في 1959 في أوديني في إيطاليا. (ar)
- Mauro Ferrari (Padua, 7 de julio de 1959) es un profesor y científico italiano. Experto en el campo de la nanotecnología y de la bioingeniería aplicada a la medicina, ha sido presidente y CEO del Houston Methodist Research Institute, director del Institute of Academic Medicine del Methodist Hospital System (TMHS) y presidente de The Alliance for NanoHealth. En enero de 2020 fue nombrado presidente del Consejo Europeo de Investigación, cargo del que dimitió en abril de 2020 por la crisis del coronavirus. (es)
- Mauro Ferrari (Udine, 7 luglio 1959) è un accademico bioingegnere e ricercatore italiano, impegnato principalmente nella ricerca sulle nanotecnologie e nel campo della bioingegneria applicate in medicina. È presidente e CEO del Houston Methodist Research Institute, direttore dal 2013 dell'Institute of Academic Medicine del Methodist Hospital System ed Executive Vice President del Methodist Hospital System (TMHS). È presidente della The Alliance for NanoHealth. (it)
- Mauro Ferrari (born 7 July 1959) is a nanoscientist and leader in the field of nanomedicine. He served as special expert on nanotechnology for the National Cancer Institute (2003-2005) and was instrumental in establishing the Alliance for Nanotechnology in Cancer in 2004.On 1 January 2020, Ferrari was made president of the European Research Council (ERC). Following a vote of no confidence, on 27 March 2020, "all 19 active members of the ERC’s Scientific Council individually and unanimously requested that Mauro Ferrari resign from his position as ERC’s President", due to poor conduct in office, exploiting the position to further his own projects, and for consistently failing to represent the interests of the ERC. On 7 April 2020, Ferrari officially resigned, stating to the media that he was (en)
|
| rdfs:label
|
- ماورو فيراري (ar)
- Mauro Ferrari (es)
- Mauro Ferrari (it)
- Mauro Ferrari (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:doctoralAdvisor
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:doctoralAdvisor
of | |
| is foaf:primaryTopic
of | |
